Exablate Prostate Treatment for Prostate Cancer

N/A

Waitlist Available

Research Sponsored by InSightec

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is for a device that is already on the market and is used to treat prostate lesions. They are collecting additional safety and effectiveness data during the 510(k) preparation and review period.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence and severity of device/procedure-related complications following treatment

Proportions of treated subjects reporting negative Gleason 7 biopsy within the prostate biopsy treatment area.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Exablate Treated ArmExperimental Treatment1 Intervention

Treatment with Exablate Prostate 2100 Type-3 System

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor

89 Previous Clinical Trials

3,700 Total Patients Enrolled

2 Trials studying Prostate Cancer

63 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being sought for this experiment?

"This investigation, which was originally published on December 19th 2019 and last modified on May 23rd 2022, is not presently seeking participants. Nevertheless, there are more than 1300 medical trials currently recruiting patients at this time."

Answered by AI

How many medical facilities are conducting this research study?

"Patients are being invited to join this clinical trial at Brigham & Women's Hospital in Boston, Massachusetts, Memorial Sloan-Kettering Cancer Center in New york City, and Mayo Clinic in Rochester, Minnesota as well as 5 additional medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

2019. "Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03998657.